Filed: 2/17/2026ACC: 0001315863-26-000165
📋 What this filing means
CRESTLINE MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $53.33M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$53.33M
Total AUM (reported)
5.02M
Total Shares
Allocation by class
COM$53.33M100.0%
Portfolio Concentration
Top 3$53.33M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 5.02M
Sole
Full voting authority
5.02M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other3
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
DENALI THERAPEUTICS INC
DFNDShares2.81M
TypeSH
Market value$46.41M
87.02%
Sole
2.81M
Shared
0.00
None
0.00
SANA BIOTECHNOLOGY INC
DFNDShares1.22M
TypeSH
Market value$4.97M
9.32%
Sole
1.22M
Shared
0.00
None
0.00
8X8 INC NEW
DFNDShares990.58K
TypeSH
Market value$1.95M
3.66%
Sole
990.58K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DENALI THERAPEUTICS INCDFND | COM | 2.81M | SH | $46.41M 87.02% | 2.81M | 0.00 | 0.00 |
SANA BIOTECHNOLOGY INCDFND | COM | 1.22M | SH | $4.97M 9.32% | 1.22M | 0.00 | 0.00 |
8X8 INC NEWDFND | COM | 990.58K | SH | $1.95M 3.66% | 990.58K | 0.00 | 0.00 |